CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851726310
- Phone
- (301) 500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- FWP Offering Free Writing Prospectus
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- DRSLTR Other Correspondence Related to Draft Registration Statement
Page 1 of 2 · 26 filings